Pharma Focus Asia

Astraea Bioseparations Expands Manufacturing and Warehousing Capacity in Massachusetts, USA

Introduction

Astraea Bioseparations is expanding its manufacturing and warehousing capacity to support chromatography solutions in Massachusetts, USA. 

Features

The new state-of-the-art facility covers an area of 12,000 square foot facility. The facility will boost the pre-packed column products and services and also creates approximately 15 new full-time positions.

The facility will house a diverse range of workspaces, featuring dedicated cleanroom laboratories for column packing services, well-appointed office areas, expansive warehousing facilities, and specialised spaces designated for column assembly.

It also includes special cleanrooms for packing columns, increased warehousing space to store all products, like the different materials used for making biologic products on a large scale. This includes range of affinity, hydrophobic interaction chromatography, and ion exchange materials. 

This expanded presence in the US is a direct response to the increasing demand for chromatography products and services, especially in the development and production of advanced biologics like cell and gene therapies.

This new site significantly enlarges footprint in the United States, growing it by more than four times its previous size. This expansion strengthens workforce of up to 9 percent over the next 18 months.

Specifications:

Name  Astraea Bioseparations
Type  Expansion
Year  2023

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference